Cyclis Pharmaceuticals
About:
Cyclis Pharmaceuticals Inc. discovers and develops novel small molecule drugs for treatment of cancer
Website: http://www.cyclispharma.com/
Top Investors: Ampersand Capital Partners
Description:
Cyclis is researching and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers.
Total Funding Amount:
$5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Norwood, Massachusetts, United States
Founded Date:
2001-01-01
Founders:
Number of Employees:
Last Funding Date:
2002-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai